Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$4.65 - $6.42 $114,390 - $157,932
-24,600 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$5.18 - $14.81 $127,428 - $364,326
24,600 New
24,600 $286,000
Q2 2019

Aug 15, 2019

SELL
$5.65 - $7.5 $66,314 - $88,027
-11,737 Closed
0 $0
Q1 2019

May 03, 2019

SELL
$3.35 - $8.27 $15,346 - $37,884
-4,581 Reduced 28.07%
11,737 $83,000
Q4 2018

Feb 08, 2019

BUY
$3.23 - $8.7 $52,707 - $141,966
16,318 New
16,318 $57,000

Others Institutions Holding ARAV

About Aravive, Inc.


  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.